SHPH
Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ)
Healthcare — Drug Manufacturers - Specialty & Generic
Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to treat cancers. It owns a pharmaceutical software artificial intelligence (AI) driven platform for molecular discovery and early-stage drug development. The company was founded in 2012 and is headquartered in Gaithersburg, Maryland.
None
$3.54
+$0.13 (+3.97%)
Sign in to add SHPH to a watchlist or set price alerts.
Price History
52-Week Range
Fundamentals
| Market Cap | $2.07M |
| P/E Ratio (TTM) | 35.35 |
| Forward P/E | - |
| EPS (TTM) | $0.10 |
| Dividend Yield | - |
| Profit Margin | - |
| Revenue Growth | - |
| ROE | -326.36% |
| Debt/Equity | 6.40 |
| Recommendation | None |
| Analyst Target | - |
| Analysts | - |
| Indexes | NASDAQ |
Technical Indicators
| RSI (14) | 41.6 |
| Beta | 1.22 |
| SMA 20 | - |
| SMA 40 | - |
| 52-Week High | $55.90 |
| 52-Week Low | $2.90 |
| 50-Day Avg | $6.05 |
| 200-Day Avg | $16.79 |
| Avg Volume | 859.5K |
| Volume | 41.1K |
Performance Analysis
NEUTRALSHPH presents a mixed picture with both positive and negative indicators.
+
Trading near its 52-week low ($2.90), which could present a value opportunity.
~
RSI at 41.6 is in neutral territory.
-
Price is below both the 50-day and 200-day moving averages — in a downtrend.
~
Wall Street consensus is "none".
Recent News
Loading news...
Last updated: Jul 02, 2026 13:31 UTC
Back to Screener Export Report